Literature DB >> 7506341

Simultaneous local pressure microejection of excitatory amino acids and field potential recording with a single micropipette in the hippocampal slice.

N B Fedorov1, K G Reymann.   

Abstract

The ability to use the same micropipette for simultaneous pressure microejection and field potential recording ('spot pressure electrode') is described. This approach allows the use of a single electrode to record both field responses to pressure microejection of drugs (fPR) and synaptically evoked field excitatory postsynaptic potentials (fEPSP). To demonstrate this, the glutamate receptor agonists alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA, 100-300 microM) and N-methyl-D-aspartate (NMDA, 1 mM) were used. Both AMPA- and NMDA-evoked fPRs exhibited properties of postsynaptic responses. Thus, they were not significantly altered by tetrodotoxin (TTX, 0.5-1 microM), but were completely and reversibly blocked by an antagonist of AMPA/kainate receptors, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 20 microM) and D-2-amino-5-phosphonopentanoic acid (AP5, 20 microM), respectively. The responses to micropressure-ejected AMPA were more stable and probably restricted to a smaller locus than responses to iontophoretic AMPA ejection. Additionally, the AMPA and NMDA contained in the pipette (up to 500 microM) did not influence the fEPSP recorded with this pipette. Our results suggest that this method might be a useful experimental tool for studying the local effects of excitatory amino acids and other compounds.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506341     DOI: 10.1016/0165-0270(93)90058-y

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  2 in total

1.  Histamine H3 receptor-mediated depression of synaptic transmission in the dentate gyrus of the rat in vitro.

Authors:  R E Brown; K G Reymann
Journal:  J Physiol       Date:  1996-10-01       Impact factor: 5.182

2.  Reversal of synaptic memory by Ca2+/calmodulin-dependent protein kinase II inhibitor.

Authors:  Magdalena Sanhueza; Charmian C McIntyre; John E Lisman
Journal:  J Neurosci       Date:  2007-05-09       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.